What can the Investment Plan for Europe do for health? (28/02/2017)
On 27 February, Member States and regional representatives, healthcare service providers, public and private investors, economists, and practice innovators took part in a seminar on strategic investments for the future of healthcare, organised by the European Commission.
Taskforce to take Health and Digital policies further (28/02/2017)
Putting the citizen at the centre of health and care re-design, the European Commission has set up a task force bringing together technology and health policy makers.
New Expert Panel on Health holds inaugural meeting and elects Chair (28/02/2017)
The new Expert Panel on effective ways of investing in health held its inaugural meeting on 24 January. On this occasion, Professor Jan De Maeseneer of the Ghent University was unanimously elected the Chair of the Expert Panel for the next 18 months.
Encouraging developments in the area of national cancer screening programmes (28/02/2017)
The implementation report on the 2003 Council Recommendation on cancer screening reveals a steep rise in national screening programmes for breast, cervical and colorectal cancer. The report also includes a set of essential indicators to document the quality of screening.
The topic of Rare Disease Day 2017 is research (28/02/2017)
28 February 2017 marks the tenth international Rare Disease Day coordinated by EURORDIS and co-funded by the EU Health Programme. The main objective is to raise awareness amongst the general public and decision-makers about rare diseases and their impact on patients' lives.
Addressing chronic diseases and healthy ageing across Europe (28/02/2017)
The final conference of the EU funded Joint Action for Chronic Diseases (CHRODIS) put forward cost-effective good practices focusing on health promotion and primary prevention, as well as the management of multi-morbidity and diabetes.
900 medical teams connect across Europe for the benefit of patients (28/02/2017)
On 1 March the newly established European Reference Networks (ERNs) will start their work. ERNs are unique and innovative cross-border cooperation platforms between specialists for the diagnosis and treatment of rare or low prevalence complex diseases.
